Je Hoon Park

Je Hoon Park

Auto-generated profile, based on publicly available information

Je Hoon Park

Department of Surgery, International St. Mary's Hospital, College of Medicine, Catholic Kwandong University, Incheon, Korea

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011 in Journal of the Korean Society of Coloproctology
Verified
Journal Article
Open access
PDF file
YCYoung Un Choi
Young Un Choi
PCPyong Wha Choi
Pyong Wha Choi
YPYong Hwan Park
Yong Hwan Park
JKJae Il Kim
Jae Il Kim
THTae Gil Heo
Tae Gil Heo
JSJeong Wook Seo
Jeong Wook Seo
Choi YU, et al. J Korean Soc Coloproctol. 2011 Jun;27(3):114-121. http://dx.doi.org/10.3393/jksc.2011.27.3.114

1 October 2004 in Transplantation Proceedings
Verified
Journal Article
Closed access
KLK.W. Lee
K.W. Lee
JPJ.B. Park
J.B. Park
JYJ.J. Yoon
J.J. Yoon
Ji-Hyun LeeJi-Hyun Lee
Ji-Hyun Lee
SKS.Y. Kim
S.Y. Kim
JJJae-Won Joh
Jae-Won Joh

14 January 2019 in BioMed Research International
Verified
Journal Article
Open access
SKSang Wook Kang
Sang Wook Kang
JPJe-Hoon Park
Je-Hoon Park
HSHosik Seok
Hosik Seok
HPHae Jeong Park
Hae Jeong Park
JCJoo-Ho Chung
Joo-Ho Chung
SKSu Kang Kim
Su Kang Kim
Chronic prostatitis typically occurs in aging men, and its symptoms include frequent and painful urination. In recent study, several studies have shown that Korean red ginseng (KRG) can be used in the prevention and treatment of various diseases. The objective of this study is to investigate whether KRG can play a role in repressing the development of chronic nonbacterial prostatitis (CNP) in male Wistar rats. To induce CNP, rats were castrated and beta-estradiol (0.25 mg/kg) was subcutaneously (s.c.) injected daily. 7-week-old male Wistar rats were divided into 5 groups (the normal group, CNP group, positive group, and KRG group (0.25g/kg) and another KRG (0.50g/kg) group. After 4 weeks, all rats were sacrificed and their prostate and serum were analyzed. Compared to the positive group, the KRG groups (0.25g/kg and 0.50g/kg) showed similar protective properties on CNP based on the histopathologic morphology of the prostate and the inflammation cytokines in the prostate tissue. Also, results of the immunohistochemistry staining showed that expression levels of vascular endothelial growth factor A (VEGFA), interleukin 6 (IL6), interleukin 1 beta (IL-1ß), tumor necrosis factor (TNF-alpha), and cytochrome c oxidase subunit II (COX2) were also decreased in KRG group (0.25g/kg) and KRG group (0.50g/kg). These results suggested that KRG inhibited the development of CNP and might a useful herbal treatment or functional food for CNP.

30 June 2016 in International Neurourology Journal
Verified
Journal Article
Open access
PDF file
JPJe Hoon Park
Je Hoon Park
SKSung Eun Kim
Sung Eun Kim
JJJun Jang Jin
Jun Jang Jin
HCHan Sung Choi
Han Sung Choi
CKChang-Ju Kim
Chang-Ju Kim
IKIL-GYU KO
IL-GYU KO
Perinatal hypoxic-ischemic brain damage is a major cause of acute mortality and chronic neurologic morbidity in infants and children. We investigated the effects of pentoxifylline, a methylxanthine derivative and type-4 phosphodiesterase inhibitor, on short-term memory and apoptotic neuronal cell death in the hippocampus following perinatal hypoxic-ischemia in newborn rats. We used a step-down avoidance task to evaluate short-term memory and 3ʹ-5ʹ-cyclic adenosine monophosphate (cAMP) assay to detect cAMP levels. We evaluated apoptosis using a terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay for evidence of DNA fragmentation, immunohistochemistry for caspase-3 levels, and western blot for Bcl-2 and Bax. Perinatal hypoxic-ischemic injury increased apoptotic cell death in the hippocampus, resulting in impaired short-term memory with decreased cAMP levels. Pentoxifylline treatment improved short-term memory by suppressing apoptotic cell death in the hippocampus with elevated cAMP levels. Pentoxifylline ameliorated perinatal hypoxic-ischemia in rat pups. This alleviating effect could be ascribed to the inhibition apoptosis due to increased cAMP production by pentoxifylline.

1 January 2011 in Journal of the Korean Surgical Society
Verified
Journal Article
Open access
PDF file
HLHo Jun Lee
Ho Jun Lee
YPYong Hwan Park
Yong Hwan Park
JKJae Il Kim
Jae Il Kim
PCPyong Wha Choi
Pyong Wha Choi
JPJe Hoon Park
Je Hoon Park
SCSurk Hyo Chang
Surk Hyo Chang
Lee HJ, et al. J Korean Surg Soc. 2011 Nov;81(5):321-325. http://dx.doi.org/10.4174/jkss.2011.81.5.321

30 April 2017 in International Neurourology Journal
Verified
Journal Article
Open access
PDF file
JPJe Hoon Park
Je Hoon Park
IKIL-GYU KO
IL-GYU KO
SKSung Eun Kim
Sung Eun Kim
JJJun Jang Jin
Jun Jang Jin
LHLakkyong Hwang
Lakkyong Hwang
DLDeok-Won Lee
Deok-Won Lee
Dexmedetomidine, an α2-adrenergic agonist, provides sedative and analgesic effects without significant respiratory depression. Dexmedetomidine has been suggested to have an antiapoptotic effect in response to various brain insults. We developed an oral mucosa patch using dexmedetomidine for sedation. The effects of the dexmedetomidine oral mucosa patch on cell proliferation and apoptosis in the hippocampus were evaluated. A hydrogel oral mucosa patch was adhered onto the oral cavity of physiologically normal rats, and was attached for 2 hours, 6 hours, 12 hours, or 24 hours. Plasma dexmedetomidine concentrations were determined by liquid chromatography- electrospray ionization-tandem mass spectrometry-multiple-ion reaction monitoring (LC-ESI-MS/MS-MRM). Cell proliferation in the hippocampus was detected by Ki-67 immunohistochemistry. Caspase-3 immunohistochemistry, terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling staining, and Western blotting for Bax and Bcl-2 were performed to detect hippocampal apoptosis. The levels of brain-derived neurotrophic factor (BDNF) and tyrosine kinase B (TrkB) in the hippocampus were also measured by Western blotting. Plasma dexmedetomidine concentration increased according to the attachment time of the dexmedetomidine oral mucosa patch. Hippocampal cell proliferation did not change due to the dexmedetomidine oral mucosa patch, and the dexmedetomidine oral mucosa patch exerted no significant effect on BDNF or TrkB expression. In contrast, the dexmedetomidine oral mucosa patch exerted an antiapoptotic effect depending on the attachment time of the dexmedetomidine oral mucosa patch. A dexmedetomidine oral mucosa patch can be used as a convenient tool for sedation, and is of therapeutic value due to its antiapoptotic effects under normal conditions.